BioSyent Named to the Growth 500 Ranking of Canada's Fastest-Growing Companies for Seventh Consecutive Year
September 12, 2019 09:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Sept. 12, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it has been named to the 31st annual Growth 500 ranking of Canada’s...
BioSyent Releases Q2 and H1 2019 Results
August 23, 2019 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Aug. 23, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three and six months ended June 30,...
BioSyent Schedules Q2 and H1 2019 Earnings Release for August 23, 2019
August 15, 2019 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Aug. 15, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and six months ended June 30,...
BioSyent Announces Withdrawal of Health Canada Submissions for Cardiovascular Products
June 26, 2019 08:00 ET
|
BioSyent Inc.
TORONTO, June 26, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) announces that it has informed Health Canada that it will be withdrawing its New Drug Submissions for two...
BioSyent to Present at Raymond James Life Sciences and MedTech Conference
June 17, 2019 15:19 ET
|
BioSyent Inc.
TORONTO, June 17, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that Mr. René Goehrum, President and CEO of BioSyent, will be presenting at the 2019...
BioSyent Releases Results for Q1 2019
May 29, 2019 08:00 ET
|
BioSyent Inc.
TORONTO, May 29, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three months ended March 31, 2019. Key highlights...
BioSyent Schedules Q1 2019 Earnings Release for May 29, 2019
May 21, 2019 08:00 ET
|
BioSyent Inc.
TORONTO, May 21, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months ended March 31, 2019 on Wednesday,...
BioSyent Announces Health Canada Approval of New Women’s Health Product
May 13, 2019 16:01 ET
|
BioSyent Inc.
TORONTO, May 13, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) announces that Health Canada has approved Tibella® (tibolone), indicated for the short-term...
FeraMAX® Named #1 by Canadian Physicians and Pharmacists for Fourth Consecutive Year
May 02, 2019 10:51 ET
|
BioSyent Inc.
TORONTO, May 02, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that for the fourth consecutive year, FeraMAX® has been named the #1 recommended iron...
BioSyent Announces Notice of Deficiency for Cardiovascular Products
March 22, 2019 16:01 ET
|
BioSyent Inc.
TORONTO, March 22, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) announces that it has been informed by Health Canada that the Company will receive a Notice of...